SBIRT vs ASCCP Management Guidelines

The SBIRT App for Screening, Brief Intervention, and Referral to Treatment for substance use provides users with detailed steps to complete an SBIRT intervention with patients or clients. The app is designed for use by physicians, other health workers, and mental health professionals and can be used with patients and clients 12 years and older. The app provides evidence-based questions to screen for alcohol, drugs and tobacco use. If warranted, a screening tool is provided to further evaluate the specific substance use. The app also provides steps to complete a brief intervention and/or referral to treatment for the patient based on motivational interviewing. Integrated within the app are three screening instruments for substance use: the CRAFFT assesses substance use in adolescents, the Alcohol Use Disorders Identification Test (AUDIT) assesses alcohol use in adults, and the Drug Abuse Screening Test (DAST) assesses drug use in the adults. The app was developed as a part of a SAMHSA-funded grant project at Baylor College of Medicine (BCM).

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.